Rotider Media stands at the forefront of Vietnam’s real estate photo and video editing industry, delivering world-class visual enhancements at highly competitive prices. With a team of skilled editors and an optimized production workflow, we help real estate agents, photographers, and developers elevate their listings, attract serious buyers, and gain an edge in today’s fast-moving property market.

Ha Noi, Vietnam, 30th Dec 2025 – Rotider Media, a Vietnam-based company providing post-production services for real estate photography and video editing, announced the expansion of its service portfolio and international availability to support real estate agents, photographers, and property developers across multiple global markets.

The company specializes in editing and optimizing visual content for property listings, virtual tours, and digital marketing platforms. Its services are designed to support standardized visual presentation, consistent quality output, and scalable production for high-volume real estate portfolios.

According to the company, the service expansion responds to increasing demand from overseas clients seeking cost-efficient and reliable post-production support for residential and commercial property marketing.

The expanded service portfolio includes real estate video editing, HDR photo editing, day-to-dusk image conversion, object removal, and virtual staging. These services support the preparation of visual materials for online property listings, agency websites, virtual tours, and social media distribution.

Real estate video editing services focus on assembling raw footage into structured video formats suitable for listing platforms and promotional use. HDR photo editing applies exposure blending techniques to balance lighting and preserve visual detail. Day-to-dusk conversion adjusts daylight images into evening scenes for visual consistency across property listings. Item removal is used to eliminate unwanted visual elements from images, while virtual staging digitally furnishes empty or outdated interiors to reflect potential usage.

Rotider Media stated that the expanded offering supports clients managing large volumes of property visuals while maintaining consistent formatting and visual standards across listings and regions.

The company was founded in Vietnam and serves clients in real estate brokerage, property development, and real estate photography. The company plans further development in workflow automation, quality control, and client integration tools throughout 2026.

Business Contact:
https://rotider.com/contact-us/

Social Channels:
Facebook: facebook.com/rotidermedia
Instagram: instagram.com/rotidermedia
YouTube: youtube.com/@rotidermedia

Media Contact

Organization: Rotider

Contact Person: Nguyen Duy Dạt

Website: https://rotider.com/

Email:
sale.rotider@gmail.com

City: Ha Noi

Country:Vietnam

Release id:39673

The post Rotider Media Expands Real Estate Editing Services Internationally appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

TN, United States, 30th Dec 2025 – BPC-157, a research peptide increasingly referenced in scientific and academic discussions, is the subject of a newly published research The Peptide Blogger, which examines the current state of evidence surrounding the compound. The review highlights sustained research interest in BPC-157 for its observed involvement in tissue protection, recovery-related mechanisms, and gastrointestinal integrity within preclinical models, while also scrutinizing the quality and limitations of the available data.

Originally identified in the early 1990s, BPC-157, short for Body Protection Compound 157, also known as Gastric Pentadecapeptide, is a synthetic peptide composed of 15 amino acids and derived from a protective protein sequence found in human gastric juice. According to the review, despite its frequent appearance in online discussions, BPC-157 is not approved for human medical use by the U.S. Food and Drug Administration or other major regulatory authorities. The analysis underscores that existing research remains largely confined to animal studies, laboratory experiments, and a small number of low-quality human observations, reinforcing the need for cautious interpretation.

A Research-First Perspective From The Peptide Blogger

According to The Peptide Blogger, the motivation behind the analysis is to address widespread confusion surrounding peptide research. The publication focuses on slowing down the conversation around compounds like BPC-157 by separating biological plausibility from proven clinical outcomes.

Rather than promoting anecdotal claims, the review evaluates peptides through published data, known cellular pathways, and study design quality. This approach reflects the site’s broader editorial mission to improve research literacy and provide context around where scientific evidence is strong, weak, or incomplete.

Scientific Overview and Observed Mechanisms

The review outlines several biological pathways through which BPC-157 has been studied in experimental models, including:

• Angiogenesis stimulation, associated with new blood vessel formation and tissue oxygenation
• Nitric oxide signaling modulation, linked to vascular function and circulation
• Gene expression regulation, related to cellular repair processes
• Growth hormone receptor interaction, explored for tissue recovery mechanisms

In laboratory and animal studies, these mechanisms have been associated with tendon, ligament, muscle, intestinal, and nerve tissue repair, along with cytoprotective and anti-inflammatory effects under stress or injury conditions. The report notes that these findings remain preclinical and should not be extrapolated to confirmed human outcomes.

Administration Forms Discussed in Research Contexts

Within research and academic discussions, BPC-157 has appeared in several experimental forms:

• Injectable formulations studied in animal models
• Oral administration examined for gastric stability
• Topical applications with minimal supporting evidence

The review stresses that none of these forms have standardized dosing guidelines or regulatory approval for therapeutic use.

Potential Benefits Suggested by Preclinical Studies

The analysis summarizes associations reported in non-human studies, including:

• Tendon, ligament, and muscle tissue repair
• Improved blood flow and vascular regeneration
• Reduced inflammation and oxidative stress
• Protection of the stomach lining and gut barrier
• Neuroprotective and cardioprotective signals in animal models

Researchers cited in the review caution that these observations have not been confirmed through rigorous, large-scale human clinical trials.

Human Evidence and Research Limitations

Human data remains extremely limited. The review references a small, uncontrolled knee-pain study that reported reduced discomfort following injections, noting the absence of control groups, standardized outcome measures, and independent oversight. The report also highlights the difficulty of separating treatment effects from natural healing processes in soft-tissue injuries.

Sports and regulatory organizations, including the World Anti-Doping Agency, continue to classify BPC-157 as prohibited for competitive athletes due to insufficient clinical transparency.

Safety Profile and Regulatory Context

Preclinical animal studies have generally shown low toxicity across various dosing schedules, with no significant organ damage observed. However, The Peptide Blogger emphasizes that limited human observations are insufficient to establish safety, long-term risk, or appropriate dosing.

The review also notes theoretical concerns related to angiogenesis in individuals with cancer or predisposition to malignancy, while clarifying that no direct causal evidence has been established.

Ongoing Scientific Interest and Responsible Interpretation

The report concludes that BPC-157 remains an active area of scientific inquiry within orthopedic research, gastrointestinal integrity studies, and neurological tissue repair models. The publication underscores the need for transparent, independent human clinical trials before any medical conclusions can be drawn.

As emphasized throughout the review, BPC-157 is currently classified as a research chemical only, and claims related to healing, performance enhancement, or disease treatment should be interpreted cautiously.

The full research analysis is available at: https://thepeptideblogger.com/bpc-157-benefits-for-health-and-recovery/.

About The Peptide Blogger

The Peptide Blogger is an independent research-focused publication dedicated to examining peptide science through published data, biological mechanisms, and evidence quality. The site covers research peptides such as BPC-157, NAD+, TB-500, MOTS-c, and related compounds, with an emphasis on study design, limitations, and the distinction between preclinical findings and validated human data. Its mission is to improve research literacy by presenting peptide science without hype, marketing claims, or anecdotal conclusions.

To learn more, visit https://thepeptideblogger.com/

Media Contact

Organization: The Peptide Blogger

Contact Person: Logan C.

Website: https://thepeptideblogger.com

Email: Send Email

State: TN

Country:United States

Release id:39702

Disclaimer: This material is provided for informational and educational purposes only. It does not constitute medical, health, or therapeutic advice, and the substances discussed are not approved for human use. Any references to research findings should be interpreted cautiously and within their scientific context.

The post Independent Research Review From The Peptide Blogger Highlights Growing Scientific Interest in BPC-157 appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

California, US, 30th December 2025, ZEX PR WIRE, Roman Meydbray, Vice President of IT, today announced the launch of a public pledge focused on transparency, accountability, and people-first practices in enterprise IT organizations. The pledge draws directly from Meydbray’s experience leading global IT teams in highly regulated healthcare and med tech environments, as well as his personal journey navigating complex systems as an immigrant and industry leader.

The pledge centers on a simple idea: IT systems work best when standards are clear, outcomes are measured, and people are treated with respect. Meydbray’s career has been shaped by operating inside strict compliance frameworks while still improving employee experience and trust.

“Working in regulated environments taught me that transparency is not optional,” Meydbray said. “When standards are clear and outcomes are measured, teams feel safer, work improves, and mistakes get addressed instead of hidden.”

He added, “I learned early in my career that setbacks can either shut you down or make you more disciplined. Accountability only works when leaders model it first.”

Meydbray also pointed to the human side of IT leadership. “Technology decisions shape how people experience their jobs every day. If IT ignores that, the system eventually breaks down.”

The Public Pledge

Through this pledge, Meydbray commits to the following actions and invites other IT leaders to do the same:

• Publish clear service standards and success metrics for IT teams

• Build feedback loops that include peers, not just executives

• Treat compliance as a baseline for trust, not a barrier to progress

• Address mistakes openly and document lessons learned

• Prioritize employee experience during system changes and integrations

Why This Matters Now

• Nearly 60 percent of healthcare data breaches are linked to process or human error, not technology failure

• Employees working under unclear IT standards report significantly lower engagement and higher burnout

• Organizations with documented IT metrics and feedback cycles are more likely to maintain compliance during mergers and acquisitions

A Simple “Do This Today” Toolkit

Readers who want to take action immediately can start with this simple toolkit:

1. Write down three IT outcomes that matter most to your organization

2. Define one metric for each outcome that can be reviewed monthly

3. Ask one peer for honest feedback on where systems fail people

4. Document one recent mistake and what changed because of it

5. Share these standards with your team in plain language

Meydbray encourages leaders at all levels to adopt the pledge publicly and share their own commitments within their organizations. The goal is not perfection, but consistency, clarity, and trust built over time.

For those who believe IT leadership should be measured by outcomes, integrity, and human impact, the pledge offers a practical starting point.

About Roman Meydbray

Roman Meydbray is a Vice President of IT based in Campbell, California. He has more than a decade of experience leading global IT and digital workplace teams in regulated healthcare and med tech environments. His work focuses on building reliable systems, clear standards, and people-first IT organizations that balance compliance, accountability, and employee experience.